Kymera Therapeutics Inc — 貸借対照表 (NASDAQ:KYMR) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 487.18 M605.9 M603.13 M575.76 M978.03 M1.74 B 負債合計 203.29 M146.27 M112.98 M180.79 M142.42 M163.15 M 純資産合計 283.89 M459.64 M490.15 M394.97 M835.62 M1.58 B 負債および純資産合計 487.18 M605.9 M603.13 M575.76 M978.03 M1.74 B 有利子負債合計 —————— 純負債 ——————

ニュース

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Kymera、Leerink Global Healthcare会議で医薬品開発の戦略的見解を提示

Kymera at Leerink Global Healthcare: Strategic Insights on Drug Development

Kymera、AAD会議でアトピー性皮膚炎試験データを発表へ

Kymera to present atopic dermatitis trial data at AAD meeting

Kymera at TD Cowen Conference: Strategic Insights on Drug Programs

Stephensが目標株価を100ドルに引き上げ、Kymera Therapeuticsのパイプラインを評価

Stephens raises Kymera Therapeutics price target to $100 on pipeline

Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway

モルガン・スタンレー、パイプライン進展を受けKymera Therapeutics株の目標株価を引き下げ